End-of-day quote
Shenzhen S.E.
03:30:00 10/05/2024 am IST
5-day change
1st Jan Change
7.07
CNY
-10.96%
+30.20%
+14.03%
Canature Health Technology Group Co., Ltd.'s Equity Buyback announced on May 16, 2022, has closed with 5,467,100 shares, representing 0.97% for CNY 31.37 million.
The company closed its plan on May 5, 2023.
Canature Health Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
22/04
CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.
01/04
CI
Canature Health Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
05/02
CI
Canature Health Technology Co., Ltd. authorized a Buyback Plan
04/02
CI
Canature Health Technology Co., Ltd. Announces Special Profit Distribution Proposal for 2023, Payable on 24 January 2024
30/12
CI
Canature Health Technology Co., Ltd. completed the acquisition of 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) on November 27, 2023.
27/11
CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
22/23/22
CI
Canature Health Technology Co., Ltd. agreed to acquire additional 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) for CNY 270 million.
10/23/10
CI
Zhuzhou Century Fengyuan Intelligent Technology Co., Ltd. completed the acquisition of additional 40.98185% stake in Spring Water Equipment Manufacturing Co., Ltd. from Canature Health Technology Co., Ltd..
20/23/20
CI
Zhuzhou Century Fengyuan Intelligent Technology Co., Ltd. signed share transfer agreement to acquire additional 40.98185% stake in Spring Water Equipment Manufacturing Co., Ltd. from Canature Health Technology Co., Ltd. for CNY 28.1 million.
23/23/23
CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
21/23/21
CI
Canature Health Technology Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023
25/23/25
CI
Canature Health Technology Co., Ltd. Announces Board Elections
23/23/23
CI
Canature Health Technology Co., Ltd. Approves Cash Dividend for the Year 2022
23/23/23
CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.
07/23/07
CI
Canature Health Technology Group Co., Ltd.'s Equity Buyback announced on May 16, 2022, has closed with 5,467,100 shares, representing 0.97% for CNY 31.37 million.
05/23/05
CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
27/23/27
CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
27/23/27
CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.
03/23/03
CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.
04/23/04
CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
24/22/24
CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.
12/22/12
CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
23/22/23
CI
Tranche Update on Canature Health Technology Group Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.
04/22/04
CI
Shanghai Origincell Biological Cryo Equipment Co., Ltd. announced that it has received CNY 410.464 million in funding from a group of investors
30/22/30
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Canature Health Technology Co Ltd is a China-based company mainly engaged in the manufacturing of water treatment products. The Company is committed to the research, development, manufacturing, sales and services of residential water treatment products and core components such as whole-house water purifiers, whole-house water softeners, commercial purified water dispensers, RO membrane reverse osmosis water purifiers, multi-way control valves, composite material pressure vessels, and membrane elements. The Company provides customized water solutions including residential water solutions, commercial water solutions, public facilities water solutions, industrial water and other special conditions. The Company sells its products domestically in China as well as in overseas markets including Europe, North America and other parts of Asia.
More about the company
1st Jan change
Capi.
+14.03% 553M +15.01% 9.05B +45.55% 2.51B -11.82% 1.04B -7.53% 765M +20.48% 696M +16.71% 679M -14.98% 601M -4.45% 580M +12.61% 561M
Purification & Treatment Equipment
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1